Osteoclastic bone resorption requires a number of complex steps that are under the control of local regulatory molecules. Osteopontin is expressed in osteoclasts and is also present in bone matrix; however, its biological function has not been fully understood. To elucidate the role of osteopontin in the process of osteoclastic bone resorption, we conducted ectopic bone implantation experiments using wild-type and osteopontin knockout mouse. In the wild-type group, bone discs from calvariae implanted ectopically in muscle were resorbed, and their mass was reduced by 25% within 4 weeks. In contrast, the mass of the bone discs from calvariae of osteopontin knockout mice was reduced by only 5% when implanted in osteopontin knockout mice. Histological analyses indicated that the number of osteoclasts associated with the implanted bones was reduced in the osteopontin knockout mice. As osteopontin deficiency does not suppress osteoclastogenesis per se, we further examined vascularization immunohistologically and found that the number of vessels containing CD31-positive endothelial cells around the bone discs implanted in muscle was reduced in the osteopontin knockout mice. Furthermore, sc implantation assays indicated that the length and branching points of the newly formed vasculatures associated with the bone discs were also reduced in the absence of osteopontin. In this assay, tartrateresistant acid phosphatase-positive area of the bone discs was also reduced in the osteopontin knockout mice, indicating further the link between the osteopontin-dependent vascularization and osteoclast accumulation. The bone resorption defect could be rescued by topical administration of recombinant osteopontin to the bones implanted in muscle. These observations indicate that osteopontin is required for efficient vascularization by the hemangiogenic endothelial cells and subsequent osteoclastic resorption of bones. (Endocrinology 142: [1325][1326][1327][1328][1329][1330][1331][1332] 2001) 
logically and found that the number of vessels containing CD31-positive endothelial cells around the bone discs implanted in muscle was reduced in the osteopontin knockout mice. Furthermore, sc implantation assays indicated that the length and branching points of the newly formed vasculatures associated with the bone discs were also reduced in the absence of osteopontin. In this assay, tartrateresistant acid phosphatase-positive area of the bone discs was also reduced in the osteopontin knockout mice, indicating further the link between the osteopontin-dependent vascularization and osteoclast accumulation. The bone resorption defect could be rescued by topical administration of recombinant osteopontin to the bones implanted in muscle. These observations indicate that osteopontin is required for efficient vascularization by the hemangiogenic endothelial cells and subsequent osteoclastic resorption of bones. (Endocrinology 142: [1325] [1326] [1327] [1328] [1329] [1330] [1331] [1332] 2001) B ONE RESORPTION requires strict control of the balance against bone formation to avoid excessive loss of bone in normal individuals. Disruption in this balance leads to osteoporosis, which is one of the major health issues in the modern aging society. Understanding the function of molecules involved in the regulation of osteoclasts, the major cells responsible for bone resorption, will contribute a great deal to develop effective measures to treat osteoporosis patients and to prevent the disease.
Osteopontin (OPN) is a cytokine and cell attachment protein. It is produced in many tissues in the body and is abundant in the extracellular matrix of mineralized tissues (1) (2) (3) . The protein contains an RGDS sequence motif that can promote attachment of several types of cells, including osteoclasts to plastic or bone (4 -6) . OPN binds to a subset of integrin receptors; most notably it is a well characterized ligand for the ␣ v ␤ 3 integrin that is expressed at high levels in osteoclasts and endothelial cells (3, 7) . Engagement of the ␣ v ␤ 3 integrin by OPN activates intracellular signaling pathways and elevates inositol polyphosphate and intracellular calcium levels in various cell types (8, 9) . The ␣ v ␤ 3 integrin is required for angiogenesis, and in vitro it is involved in inhibition of endothelial cell death via an NF-B-mediated pathway (10, 11) . OPN acts as a cytokine, and its binding to ␣ v ␤ 3 activates c-Src and phosphoinositide-3-hydroxy kinase (12, 13) . As one consequence of the activation of intracellular signaling pathways, OPN suppresses the induction by lipopolysaccharide and interferon-␥ of nitric oxide synthesis induced in kidney proximal tubule epithelial cells by inhibiting the induction of the inducible nitric oxide synthase messenger RNA (14) . OPN is also produced at high levels by macrophages in granulomas associated with tuberculosis, silicosis, or reactions to foreign bodies (15) (16) (17) .
In bone, OPN is produced by osteoblasts when they form bone matrix and is subsequently accumulated in the mineralized matrix. OPN binds strongly to hydroxyapatite, possibly explaining its abundance in bone matrix. OPN is also expressed at high levels in osteoclasts (18, 19) . These observations suggest that OPN could play a role in the attachment of bone cells to bone and in controlling subsequent bone cell functions such as bone resorption. However, the function of OPN in bone as well as other tissues is not known.
Recently, OPN knockout mouse strains have been established by homologous recombination in mouse embryonic stem cells (20, 21) . These mice are fertile and mature normally, with apparently unaltered development of most tissues and organs examined to date. Their skeletal patterning is also normal. Because OPN has been shown to be an extracellular signaling molecule for osteoclasts and endothelial cells in vitro (3), we investigated the consequences of the absence or presence of OPN in vivo on the angiogenesis, accumulation of osteoclasts, and subsequent bone resorption by using an ectopic bone-resorbing model in which wildtype and OPN-deficient bone discs were implanted into wild-type and OPN knockout mice, respectively.
Materials and Methods

Preparation of bone discs
Wild-type or OPN-deficient mice with a C57BL/6 ϫ 129S3 background were prepared as described by Rittling et al. (20) . For implantation, disc-shaped bones with a diameter of 2.5 mm were prepared by punching out discs from the centers of parietal bones of either wild-type or OPN-deficient mice. In certain experiments, pairwise comparisons were made of bone discs prepared from the right and left parietal bones of the same animal. Calvariae were dissected from the mice and were frozen overnight or used directly for preparation of the bone discs. For each of the parietal bones, only one bone disc per parietal bone was prepared. Before implantation, these bone discs were radiologically examined by taking soft x-ray pictures (40 kV, 2 mA, 15 sec). The discs were then washed in PBS at 4 C, immersed in 70% ethanol for 1 min at room temperature, and rinsed again in PBS immediately before implantation. Bone discs prepared from wild-type and OPN-deficient mice were implanted into the midback of the wild-type and OPN-deficient host mice (1.5-to 3.5-month-old female mice), respectively. Animal experiments were conducted according to the guidelines for animal studies in our institute.
Intramuscular implantation of bone discs
A single skin incision was made in the back of the anesthetized host animal. The bone discs were individually implanted into pockets made in the paravertebral muscles of either wild-type or OPN-deficient mice. Wild-type bone discs and OPN-deficient bone discs were implanted into the muscles of wild-type and OPN-deficient mice, respectively. The shape and location of the bone discs were monitored by soft x-ray analysis of the animals under anesthesia. All discs were excised 4 or 8 weeks after implantation, fixed with 2.5% glutaraldehyde/PBS, and then subjected to soft x-ray examination (25 kV, 50 mA, 2 sec). The levels of resorption of bone discs were calculated as follows. The resorbed area of each disc was quantitated using an image analyzer equipped with the Luzex system (NIRECO, Tokyo, Japan), and the value was normalized against the initial size of the bone discs (2.5 mm in diameter).
Subcutaneous implantation of bone discs
Subcutaneous pockets were made in the backs of the animals by opening the tips of the inserted scissors. The bone discs were then placed into the pockets. The location and shape of the bone discs in vivo were monitored periodically by soft x-ray analysis of the animals under anesthesia. All of the sc implanted bone discs were excised 3 months after implantation. Photographs of the bone discs were taken at the time of excision, and vessels on the bone discs were traced to OHP film. Then the lengths of the vessels were quantified using an image analyzer equipped with the Luzex system. To quantitate only neovascularization, very thick vessels (Ͼ0.04 mm) were eliminated from consideration. The number of branch points of the vessels was determined using the photographed records of the excised bones. Some of the bone discs were subjected to en bloc staining for tartrate-resistant acid phosphatase (TRAP) activity, and the stained area was quantitated by the image analyzer.
Histochemical staining for TRAP activity
Bone discs implanted im were excised 4 weeks after implantation, fixed with 4% paraformaldehyde, and decalcified with 20% EDTA for 2 weeks at 4 C. After dehydration and paraffin embedding, serial sections at 5-m thickness were prepared. Sections were made in a plane perpendicular to the plane of the bone disc within its central part along the diameter. To estimate the accumulation of osteoclasts on the bone discs implanted in muscle, sections were stained for TRAP activity by immersing the sections in a buffer (pH 5.0) containing sodium acetate (100 mm), sodium tartrate (50 mm), naphthol phosphate AS-MX (0.1 mg/ml), N,N-dimethyl formamide (1%), Fast Red Violet LB salt (0.6 mg/ml), and manganese (II) chloride (0.4 mm) at room temperature for 10 min. The sections were counterstained with Alcian Blue. Osteoclasts were identified as TRAP-positive cells attached to bone. These cells were counted in five sections (for each of the five bones per group), which were 150 m apart. The average number of osteoclasts per bone section was obtained for each of the bone discs.
Immunohistochemistry and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) assay
Bone discs implanted im were excised 4 weeks after implantation and were fixed and decalcified as described above. The serial sections at 5-m thickness of the im implanted bone discs obtained as side by side sections used for TRAP staining were incubated at 4 C overnight with MEC 13.3 rat monoclonal antimouse PECAM-1 (CD31) antibody (PharMingen, San Diego, CA). The sections were then incubated at room temperature for 1 h with biotinylated goat antirat IgG antibody (Biosource Technologies, Inc., Camarillo, CA) and visualized with peroxidase-conjugated avidin using the Vectastain kit (Vector Laboratories, Inc., Burlingame, CA) and diaminobenzadene. The PECAM-1 (CD31)-positive new vessels around the bone discs within 260 m at their edges were counted in five serial sections, 150 m apart, in the central part of the bone discs. The average number of vessels per section was obtained for each of the bone discs. We made sure that the soft tissues around the implants, which contained the vessels, were recovered quantitatively for both groups by excising the implants with relatively large bulks of surrounding muscles. By examination of the histological sections, it was clear that most of the neovascularization was within the region 260 m away from the bone discs, as no major neovascularization was observed in the outer regions (Ͼ260 m away from the bone discs), which were still within all histological sections. The TUNEL assay was conducted using the side by side sections from these bone discs according to the manufacturer's instruction (TaKaRa, Tokyo, Japan).
Restoration of impaired resorption of OPN-deficient bone by treatment of the bone discs with OPN
Bone discs were prepared as described above from calvarial bones of wild-type or OPN-deficient mice. Glutathione-S-transferase (GST)-OPN fusion protein and GST were prepared as described previously (21) . The bone discs were immersed for 3 h at 4 C in either recombinant GST-OPN fusion protein solution (0.375 mg/ml in PBS) or GST protein (0.375 mg/ml in PBS) as controls. These discs were then immersed in 70% ethanol for 1 min, rinsed in PBS, and then immediately implanted into the pockets made in the right or left paravertebral muscles of host wild-type or OPN-deficient mice as described above. The GSTimmersed bone discs were implanted into the pocket on the left side, and GST-OPN-immersed bone discs were implanted in the right side. These experiments were conducted in a pairwise manner using the bone disc from one side of the parietal bone for treatment with GST-OPN fusion protein treatment and that from the other side for GST treatment. Bone discs were monitored by soft x-ray and were excised 8 weeks after implantation.
Results
OPN is required for efficient resorption im
When the bone discs are implanted in a muscle environment, significant bone resorption occurs within 4 weeks. Initiation of bone resorption in wild-type bone discs was observed by soft x-ray examination of live mice as early as 3 weeks after im implantation in wild-type mice. Therefore, we excised all the bone discs after 4 weeks. As shown in Fig.  1A , soft x-ray examination indicated that the wild-type bone discs implanted in wild-type mice were significantly resorbed. In contrast, bone resorption was severely impaired when bone discs from OPN knockout mice were implanted im in OPN knockout mice. Quantification of the resorbed area revealed that about 25% of the total area was lost in wild-type mice, whereas only 5% was lost in the OPNdeficient group (Fig. 1B) . These results indicate that OPN is required for efficient resorption of im implanted bones.
To further examine the effects of OPN deficiency in either bone discs or host alone, two additional groups of combinations, including OPN-deficient bone discs implanted into wild-type mice and wild-type bone discs implanted into OPN-deficient mice, were investigated. Intermediate levels of bone resorption were observed when either the bone discs alone or the host alone was deficient in OPN (Fig. 1A) . The resorbed areas in the bone discs in these groups were about 11% and 13%, respectively (Fig. 1B) . Overall, these data establish that OPN in both the host and bone discs is required for efficient resorption of im implanted bones.
Osteoclast accumulation at the implanted bone disc was impaired in the absence of OPN
To obtain insight into the underlying mechanism of the effect of OPN deficiency at the cellular level, we further examined the osteoclasts attached to the im implanted bone discs using histological sections of the bone discs stained for TRAP activity. Osteoclasts were observed at the edge of the bone discs in both wild-type ( Fig. 2A) and OPN knockout mice groups (Fig. 2B) . The TRAP activity of osteoclasts as well as the morphology of the lacunae formed by the individual osteoclasts were similar regardless of the genotype (Fig. 2, A and B) . However, quantification of the number of osteoclasts indicated reduction in the OPN knockout mice group compared with wild-type group (Fig. 2C) . Thus, the reduction in bone resorption was at least in part due to the reduction in the number of osteoclasts resorbing the ectopically implanted bone discs in OPN knockout mice group.
Vascularization onto the bone discs is impaired by OPN deficiency
As osteoclasts are derived from hemopoietic precursor cells, the reduction of osteoclasts could be due to the defect in the ability of the precursors to differentiate into osteoclasts. However, no defects in the capability of osteoclastic differentiation have been observed in bone marrow cells or spleen cells derived from OPN-deficient mice (20) . Therefore, we examined the possibility that neovasularization is affected by the absence of OPN. To quantitate neovascularization of the bone discs in the muscle, the sections were immunostained with antibody raised against an endothelial cell-specific marker, PECAM-1 (CD31). The number of vessels stained positively for PECAM-1 (CD31) around the edges of the bone discs was decreased in the absence of OPN compared with those in the presence of OPN [wild-type, 70.19 Ϯ 21.18 (n ϭ 5); OPN knockout, 43.04 Ϯ 21.58 (n ϭ 6); P Ͻ 0.01]. As it has been reported that endothelial cell apoptosis in vitro is suppressed by ␣ v ␤ 3 integrin-mediated sig-FIG. 1. Resorption of ectopically implanted bone discs is impaired in the absence of OPN. Bone discs were implanted into muscle of host mice as described in Materials and Methods and were excised 4 weeks later. A, Soft x-ray pictures of the excised bone discs. B, Quantification of the bone resorption area of bone discs implanted into host mice shown in A. WT, Bone disc and implanted mice are wild type; KO, bone disc and implanted mice are OPN deficient. *, The difference is statistically significant (P Ͻ 0.05). nals (10, 11) , the presence of apoptotic cells around the bone discs in vivo was examined according to TUNEL assay using side by side sections of the bone discs used for the detection of PECAM-1 (CD31). TUNEL signals associated with PECAM-1 (CD31)-positive cells were very rare in the presence or absence of OPN in bone discs and host mice (data not shown).
Although im implantation experiments were useful for bone resorption assay, they are less useful for analysis of the length or branching of the vasculatures because the surrounding muscle tissues were tightly attached to the bone discs when the bone discs were excised, and this made such analyses impossible. In contrast, sc implantation allows us to examine the OPN effects on the above-mentioned neovascularization due to the characteristics of the loose sc tissues in this environment, although slow rates of vascularization of bone discs result in prolonged times required for observable bone resorption, as we did not see bone resorption within 3 months. Thus, to further analyze the effect of OPN deficiency on the neovascularization, we implanted bone discs sc in the backs of the mice.
When the bone discs were excised under a dissecting microscope 3 months after implantation, vascularization of the implanted bone discs was readily observed (Fig. 3AB) . To quantitate the angiogenic response to the wild-type or OPNdeficient bone discs, the length of the vasculature attached on the surface of each bone disc was measured. The length of the vessels was about 3-fold higher in wild-type than in OPNdeficient mice (Fig. 3C) . To further evaluate angiogenic activity, the number of branch points of the vessels was also counted. As shown in Fig. 3D , the number of branch points in wild-type animals was 3-fold higher than that in the OPNdeficient group.
To examine whether such differences in vascularization in the sc environment also affect accumulation of osteoclasts, bone discs were subjected to en bloc staining for TRAP. En bloc staining of the bone discs for TRAP activity indicated accumulation of osteoclasts at the edges of the bone discs in FIG. 2 . The number of osteoclasts adherent to the surface of the bone discs implanted in muscle is reduced in the absence of OPN. Bone discs implanted into muscle were decalcified with 20% EDTA, dehydrated in graded concentrations of ethanol, and embedded in paraffin. Sections were made (5 m thick) and stained for TRAP activity. Histochemical analysis revealed that TRAP activity in the individual osteoclasts resorbing the bone discs in vivo was similar regardless of the presence (A) or the absence (B) of OPN in the bone discs or host mice. C, Quantitation of the osteoclasts observed on the bone discs implanted in muscle. WT, Bone disc and implanted mice are wild type; KO, bone disc and implanted mice are OPN deficient. Each group consists of the data from five bone discs. *, The difference is statistically significant (P Ͻ 0.05).
wild-type mice (Fig. 4A) . In contrast, such accumulation of osteoclasts was reduced in OPN knockout mice (Fig. 4A) . Quantification of the TRAP-positive area on the bone discs indicated that 35% of the total area was covered by TRAP staining in wild-type mice, whereas the TRAP-positive area was reduced to 25% in the absence of OPN (Fig. 4B) . The bone discs were also sectioned after the en bloc staining for TRAP. These histological examinations indicated the presence of TRAP-positive multinucleated cells attached to the bone discs. These observations based on the two types of bone implantation models establish that OPN facilitates vascularization of ectopically implanted bone and accumulation of osteoclasts.
Bone-resorbing activity was rescued by the exogenous OPN
To examine whether impairment in the resorption of the bone discs was due solely to OPN deficiency in the bone discs and/or the lack of OPN provided to the site of implantation from the host, we performed reconstitution experiments by supplying recombinant OPN (22, 23) to the OPN-deficient bone to determine whether that would restore susceptibility to bone resorption. The bone discs were immersed in a solution containing GST-OPN fusion protein or GST protein alone before implantation into the muscle of host mice. The bone discs were excised 8 weeks after implantation, and bone resorption was evaluated. As shown in Fig. 5 , OPN-deficient bone discs treated with GST-OPN fusion protein were resorbed more efficiently than the control GST proteintreated bone discs.
Discussion
On the role of OPN in osteoclastic bone resorption in vivo
Our data establish that OPN is required for efficient resorption of ectopically implanted bone discs by osteoclasts. Osteoclasts accumulating in bone discs are responsible for the bone resorption observed in our im implantation system, FIG. 3 . Vascularization of ectopically implanted bone discs requires OPN. Bone discs were implanted sc and excised 3 months after implantation, before initiation of the marginal resorption of the edges of the bone discs (A-B). During excision, the vascularization of the implanted bone discs was examined under a dissecting microscope, and photos of both sides of each disc were taken to record the vasculatures on the surface of the discs as well as the area surrounding the implanted bone discs. The length (C) and the number of branch points (D) of the blood vessels on the surface of each bone disc (both sides) were measured. Eight bone discs were used per each group. WT, Bone disc and implanted mice are wild type; KO, bone disc and implanted mice are OPN deficient. *, The difference is statistically significant (P Ͻ 0.05).
as TRAP staining of the histological sections of the discs implanted in muscle revealed the presence of these cells. These osteoclasts formed lacunae and expressed TRAP at similar levels regardless of the presence or absence of OPN in vivo. However, quantitation of the number of osteoclasts revealed that accumulation of these cells on the bone discs implanted in muscle was impaired by OPN deficiency, indicating that this impairment in the accumulation of osteoclasts at least in part contributed to the reduction in bone resorption.
Bone matrix contains type I collagen as the major component, making up approximately 90% of the organic fraction. Noncollagenous bone matrix proteins, including osteocalcin, biglycan, osteonectin, and matrix Gla protein, have been shown to play roles in bone metabolism based on studies of knockout mice (24 -27) . OPN is also one of the most abundant noncollagenous bone matrix proteins in bone. In vitro experiments have shown that OPN can promote attachment of cells and stimulate signaling events in osteoclasts. However, knockout mice deficient in OPN did not reveal a major bone phenotype, at least during the early period of their life under typical laboratory conditions (20) . We hypothesized that OPN is required for the situation where osteoclastic bone resorption is enhanced. As the data in this paper indicate, the role of OPN in bone resorption is apparently more pronounced under circumstances of accelerated, pathological bone loss. Such situations also include the rapid bone loss that occurs after ovariectomy (1) . It may be that under some circumstances OPN-dependent osteoclastic recruitment can be compensated, perhaps by the closely related protein BSP-1 and/or osteoclast-regulating cytokines such as receptor activator of nuclear factor-B ligand (28, 29) . However, under conditions of rapid bone resorption, there is a strict requirement for OPN function. Our observation that exogenously supplied OPN increases bone resorption area in the implanted bone discs confirms the importance of this protein in this model of bone loss.
On the role of OPN in angiogenesis
As OPN deficiency per se does not suppress osteoclast development from hemopoietic precursor cells in the cultures of bone marrow cells and spleen cells (20) , we investigated whether OPN deficiency affects angiogenesis to ectopically implanted bone discs. The reduced number of PECAM-1-positive vessels on the im implanted bone discs in the absence of OPN indicated that angiogenesis was deficient under these conditions, as PECAM-1 is a marker of endothelial cells. In addition, quantitation of vessels around the bone discs in sc implantation experiments revealed that angiogenesis was impaired by the lack of OPN. Thus, OPN is required for efficient angiogenesis to ectopically implanted bone discs.
Previous in vitro experiments indicated that apoptosis of endothelial cells is promoted by the absence of the ligands for ␣ v ␤ 3 integrin such as OPN and vitronectin (10) , and that endothelial cell proliferation can be promoted by adhesion to ␣ v ␤ 3 ligands in culture (30) . However, our results showed no elevation of TUNEL signals in the PECAM-1 (CD31)-positive endothelial cells associated with the bone discs in vivo. This observation indicates that in vivo, differences in apoptotic rates do not account for the OPN effects on vascularization. It is likely that vitronectin or other molecules may have compensated for the absence of OPN in the prevention of apoptosis in vivo. Whether other mechanisms, such as a reduction in chemotaxis (31, 32) or ␤ 3 integrin-dependent phenomena (33), may be affected by the absence OPN-deficient resulting in suppression of angiogenesis as well as osteoclast accumulation and/or function is a subject for further investigation. Our observation that osteoclasts on the ectopically implanted bone discs were similar in shape, TRAP activity, and morphology of their lacunae regardless of the genotype suggests that OPN deficiency did not significantly affect the differentiation and/or function of individual osteoclasts in vivo.
On the bone disc implantation
In our experiments, round bone discs were implanted into muscle of knockout and wild-type mice. Intramuscular implantation revealed the consequences of OPN deficiency on resorption in 4 weeks. As shown in the data in Fig. 1 , there was a small, but certain, bone resorption in the OPN-deficient bone discs; therefore, it is reasonable to assume that they catch up to the wild-type bone at a later time point. This implantation system using round bone discs has an advantage over the previously reported bone particle implantation system, as it is amenable to several kinds of analyses: 1) simple evaluation of the resorption levels by taking x-ray films of the bone discs before and after the 4-week implantation in muscle, and 2) sequential monitoring of the degree of resorption (even a small degree of resorption can be visualized as a notch in the margin of the bone disc seen in x-ray analysis).
Although the data obtained in this system support the role for OPN in normal osteoclastic function and bone remodeling, it is not a perfect model of normal and pathological remodeling in bone. These studies could be extended to include studies examining fracture remodeling and PTHinduced remodeling in OPN-deficient mice. In addition, the reduced numbers of osteoclasts and apparent decrease in vascularization could be part of a very complex process involving defective inflammatory responses associated with tissue injury. Therefore, further analyses are required to reveal the mechanisms or sites of action of OPN in these process.
In conclusion, we have demonstrated in vivo that the absence of OPN impairs angiogenesis, subsequent osteoclast accumulation, and eventual bone resorption of ectopically implanted bones. OPN present in bone matrix, therefore, acts as a molecule required for bone resorption in vivo, at least in response to stress as shown in the ectopic bone implantation. The levels of bone resorption in the im implanted bone discs were quantified using an image analyzer equipped with the Luzex system as described above. Each group consists of the data obtained from nine bone discs. *, The difference is statistically significant (P Ͻ 0.05).
